Company attributes
Industry
Location
B2X
AngelList URL
Pitchbook URL
Legal Name
Bellicum Pharmaceuticals, Inc.
Date Incorporated
July 1, 2003
Number of Employees (Ranges)
1 – 10
Email Address
robert.uhl@westwicke.com0
Phone Number
+128145434240
Full Address
3730 Kirby Drive, Suite 1200 Houston, Texas 770980
Life Science Plaza, 2130 West Holcombe Blvd, Suite 850, Houston, TX 77030, US
CIK Number
DUNS Number
962765991
IRS Number
201,450,200
Founded Date
January 1, 2003
Total Funding Amount (USD)
32,500,000
60,100,000
66,900,000
Latest Funding Round Date
2014
March 8, 2012
Business Model
Commerce
Licensing
Stock Symbol
BLCM0
Exchange
Board of Directors
Also Known As
Bellicum Pharmaceuticals
Latest Funding Type
NAICS Code
325,412
CAGE Code
62JB2
Patents Assigned (Count)
8
Wellfound ID
Country
Other attributes
Company Operating Status
Active
Contact Page URL
Latest Funding Round Amount (USD)
34,400,000
20,000,000
SIC Code
2,834
Ticker Symbol
BLCM
Wikidata ID
Bellicum is a clinical-stage biopharmaceutical company that is driving the future of cellular IO. It discovers and develops product candidates in some of the most important areas of cellular immunotherapy, with a focus on CAR-T and CAR-NK therapies.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
